The National Institutes of Health awarded $41 million to the Boston University Clinical & Translational Science Institute to support its work translating scientific research into new treatments and healthcare technologies.
The seven-year grant was awarded through the NIH National Center for Advancing Translational Sciences.
Funding will support research resources, pilot funding, training and mentoring, access to core facilities and data, and community engagement programs.
Founded in 2008, the institute is a partnership between Boston University and Boston Medical Center Health System.
Under the new award, the Veterans Affairs Boston Healthcare System will join the institute’s leadership.
The CTSI connects scientists, engineers, clinicians, patients, and community partners to accelerate research from early discovery through clinical application.
Its programs have supported research across individualized medicine, infectious disease, stroke recovery, overdose prevention, regenerative medicine, and other areas.
The award is part of NCATS’ Clinical and Translational Science Awards Program.
It will also be accompanied by a research training grant for predoctoral students.
KEY QUOTES:
“Our vision is to bring new discoveries to the communities that we serve, patients, scientists, and students. We’re really looking to be, and have been, an institute that starts with educating and ends with products that help improve individuals’ health and cure disease.”
David Center, Founding Principal Investigator of the BU Clinical & Translational Science Institute and Associate Provost for Translational Research at Boston University
